Literature DB >> 3486878

Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes.

S E Shoelson, S Marshall, H Horikoshi, O G Kolterman, A H Rubenstein, J M Olefsky.   

Abstract

An insulin-requiring diabetic patient with intermittent periods of increased insulin requirements and insulin resistance was studied. The patient was found to have high titers of antiinsulin antibodies; subfractionation of the patient's serum revealed several populations of antiinsulin antibodies with differing affinities and titers for insulin. The ability of one of the insulin antibody fractions to bind [125I]iodoinsulin was markedly inhibited by the patient's serum (insulin depleted) and by purified total immunoglobulin G from which antiinsulin antibodies and insulin were removed. These findings suggested an antiidiotypic antibody in the patient's immunoglobulin G fraction reacting specifically with the antiinsulin antibody subfraction. Finally, the patient's serum contained an antiinsulin receptor antibody, as demonstrated by the ability of serum to specifically immunoprecipitate covalently labeled soluble insulin receptors. In conclusion, these results suggest that this patient generated a widespread polyclonal response to insulin, with the development of several populations of antiinsulin antibodies. An antiidiotypic antibody to a specific insulin antibody subfraction was present in the patient's serum which we believe had structural similarity to the binding site of the insulin molecule, accounting for the reactivity of the antiidiotypic antibody with the insulin receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486878     DOI: 10.1210/jcem-63-1-56

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

Review 2.  Idiotypes and anti-idiotypes: what are they trying to tell us?

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

3.  Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.

Authors:  M Wettendorff; D Iliopoulos; M Tempero; D Kay; E DeFreitas; H Koprowski; D Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  An idiotope-specific autoantibody in SLE.

Authors:  C G Mackworth-Young; R S Schwartz
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

5.  Insulin receptor antibodies in diabetes mellitus.

Authors:  H Batarseh; R A Thompson; O Odugbesan; A H Barnett
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

6.  Association of type B insulin resistance and type 1 diabetes resulting in ketoacidosis.

Authors:  Olivier Bourron; Corinne Vigouroux; Marine Halbron; Elia Belle Touati; Emilie Capel; Martine Caron-Debarle; Agnès Hartemann
Journal:  Diabetes Care       Date:  2012-02       Impact factor: 19.112

Review 7.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.